Search Results - "Subhan, Maryam"

A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX) by Arulkumaran, Nishkantha, Thomas, Mari, Stubbs, Matthew, Prasanna, Nithya, Subhan, Maryam, Singh, Deepak, Ambler, Gareth, Waller, Alessia, Singer, Mervyn, Brealey, David, Scully, Marie

“…COVID-19 disease is associated with a hyperinflammatory, pro-thrombotic state and a high mortality. Our primary objective was to assess the change in…”
Get full text

Unusually high ADAMTS13 activity in a patient with congenital thrombotic thrombocytopenic purpura by Subhan, Maryam Owais, Groot, Rens, Scully, Marie

Get full text

P1612: CALPROTECTIN LEVELS ARE ELEVATED IN CONGENITAL TTP AND IMMUNE TTP AT ADAMTS13 RELAPSE by Subhan, Maryam, Dragunaite, Bertina, Scully, Marie, De Groot, Rens

Get full text

Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura by Shin, Jin-Sup, Subhan, Maryam Owais, Cambridge, Geraldine, Guo, Yanping, de Groot, Rens, Scully, Marie, Thomas, Mari

“…T follicular helper (Tfh) cells regulate development of antigen-specific B-cell immunity. We prospectively investigated B-cell and cTfh subsets in 45 immune…”
Get full text

ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpura by Singh, Deepak, Subhan, Maryam Owais, de Groot, Rens, Vanhoorelbeke, Karen, Zadvydaite, Almina, Dragūnaitė, Bertina, Scully, Marie

“…ADAMTS13 activity is one of the key investigations needed to diagnose thrombotic thrombocytopenic purpura, and there are a number of different assays available…”
Get full text

Ethical Foundations of the Islamic Financial Industry by Azmat, Saad, Subhan, Maryam

“…This paper examines the ethical foundations of the Islamic financial industry which is strongly criticized for its similarity with conventional finance. In…”
Get full text

Comparing the Impact of Rituximab Dosing on Longitudinal ADAMTS13 Parameters in TTP by Subhan, Maryam, Prasannan, Nithya, Dragunaite, Bertina, Vanhoorelbeke, Karen, Scully, Marie, Thomas, Mari

“…Introduction The use of rituximab to prevent clinical TTP relapse is widely accepted practice. However, the optimal dosing and regimen remains unclear with a…”
Get full text

Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura by Prasannan, Nithya, Dragunaite, Bertina, Subhan, Maryam, Thomas, Mari, de Groot, Rens, Singh, Deepak, Vanhoorelbeke, Karen, Scully, Marie

“…•Closed ADAMTS13 conformation at peak ADAMTS13 activity significantly reduced relapse rates by eightfold in 1 year and fivefold 2 years.•Longitudinal data…”
Get full text

Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19 by Wilson, Andrew J., Troy‐Barnes, Ethan, Subhan, Maryam, Clark, Fiona, Gupta, Rajeev, Fielding, Adele K., Kottaridis, Panagiotis, Mansour, Marc R., O'Nions, Jenny, Payne, Elspeth, Chavda, Naina, Baker, Robert, Thomson, Kirsty, Khwaja, Asim

Get full text

Unusually high ADAMTS13 activity in a patient with congenital thrombotic thrombocytopenic purpura by Subhan, Maryam Owais, de Groot, Rens, Scully, Marie

Get full text

Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19 by Wilson, Andrew J, Troy-Barnes, Ethan, Subhan, Maryam, Clark, Fiona, Gupta, Rajeev, Fielding, Adele K, Kottaridis, Panagiotis, Mansour, Marc R, O'Nions, Jenny, Payne, Elspeth, Chavda, Naina, Baker, Robert, Thomson, Kirsty, Khwaja, Asim

Get full text